Catherine R Degnin
Overview
Explore the profile of Catherine R Degnin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yahya J, Herzig D, Farrell M, Degnin C, Chen Y, Holland J, et al.
J Gastrointest Oncol
. 2018 Jul;
9(3):441-447.
PMID: 29998009
Background: Management of rectal cancer with involved lateral pelvic lymph nodes (LPLNs) at the time of diagnosis-the stage we refer institutionally to as Stage 3.5-is controversial. The American Joint Committee...
2.
Yahya J, Farrell M, Herzig D, Degnin C, Chen Y, Holland J, et al.
J Gastrointest Oncol
. 2018 Jul;
9(3):435-440.
PMID: 29998008
Background: Accurate staging is crucial for management of patients with newly diagnosed rectal cancer. Endorectal ultrasound (EUS) has been the standard modality in the United States for decades, with magnetic...
3.
Nabavizadeh N, Waller J, Fain 3rd R, Chen Y, Degnin C, Elliott D, et al.
Int J Radiat Oncol Biol Phys
. 2018 Feb;
100(3):577-585.
PMID: 29413273
Purpose: To report the toxicities and outcomes for stereotactic body radiation therapy (SBRT) and accelerated hypofractionated radiation therapy (AHRT) in patients with Child-Pugh (CP) class A, B, or C and...
4.
Degnin C, Laederich M, Horton W
Mol Biol Cell
. 2011 Aug;
22(20):3861-73.
PMID: 21865593
Fibroblast growth factor receptor 3 (FGFR3) is a major negative regulator of bone growth that inhibits the proliferation and differentiation of growth plate chondrocytes. Activating mutations of its c isoform...
5.
Laederich M, Degnin C, Lunstrum G, Holden P, Horton W
J Biol Chem
. 2011 Apr;
286(22):19597-604.
PMID: 21487019
Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of growth and differentiation, whose aberrant activation causes a number of genetic diseases including achondroplasia and cancer. Hsp90 is a...
6.
Tryfonidou M, Lunstrum G, Hendriks K, Riemers F, Wubbolts R, Hazewinkel H, et al.
Dev Dyn
. 2011 Feb;
240(3):663-73.
PMID: 21337464
We report the generation of a new mouse strain harboring a Col2-pd2EGFP reporter transgene; pd2EGFP has a much shorter half-life than EGFP, making it a near real-time reporter for Col2α1...
7.
Degnin C, Laederich M, Horton W
J Cell Biochem
. 2010 Jun;
110(5):1046-57.
PMID: 20564212
The mammalian skeleton developments and grows through two complementary pathways: membranous ossification, which gives rise to the calvarial bones and distal clavicle, and endochondral ossification, which is responsible for the...
8.
Horton W, Degnin C
Trends Endocrinol Metab
. 2009 Sep;
20(7):341-8.
PMID: 19716710
The mammalian skeleton forms and grows through two developmental pathways: membranous ossification, which gives rise to calvarial bones and the distal clavicle, and endochondral ossification, which is responsible for the...
9.
Guo C, Degnin C, Laederich M, Lunstrum G, Holden P, Bihlmaier J, et al.
Cell Signal
. 2008 May;
20(8):1471-7.
PMID: 18485666
Thanatophoric dysplasia is a member of the achondroplasia family of human skeletal dysplasias, which result from FGFR3 mutations that exaggerate this receptor's inhibitory influence on chondrocyte proliferation and differentiation in...